| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3540240 | A | Drug excretion in F344/DuCrlCrlj rat urine at 1 mg/kg, po administered via gavage measured during 0 to 48 hrs by radio-HPLC analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 2. | ALA3540241 | A | Drug excretion in F344/DuCrlCrlj rat bile at 1 mg/kg, po administered via gavage measured during 0 to 48 hrs by radio-HPLC analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 3. | ALA3540242 | A | Drug excretion in F344/DuCrlCrlj rat urine/bile at 1 mg/kg, po administered via gavage measured during 0 to 48 hrs by radio-HPLC analysis | Rattus norvegicus | 1 | organism-based format | Scientific Literature | ||
| 4. | ALA3537605 | P | Retention time of the compound by LC-MS/MS analysis | 21 | small-molecule physicochemical format | Scientific Literature | |||
| 5. | ALA3537606 | A | AUC (0 to t) in F344/DuCrlCrlj rat plasma treated with rivoglitazone at 1 mg/kg, po administered via gavage by LC-MS/MS analysis | Rattus norvegicus | 10 | organism-based format | Scientific Literature | ||
| 6. | ALA3537607 | A | AUC (0 to t) in monkey plasma treated with rivoglitazone at 1 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 15 | organism-based format | Scientific Literature | ||
| 7. | ALA3532180 | A | Oral bioavailability in monkey at 0.0986 mg/kg administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 8. | ALA3532515 | A | AUC (0 to t) in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 9. | ALA3532516 | A | AUC (0 to infinity) in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 10. | ALA3532517 | A | Cmax in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 11. | ALA3532518 | A | Tmax in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 12. | ALA3532519 | A | Terminal elimination half life in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 13. | ALA3532520 | A | Apparent total clearance in monkey at 0.493 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 14. | ALA3532521 | A | Oral bioavailability in monkey at 0.493 mg/kg administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 15. | ALA3532522 | A | AUC (0 to t) in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 16. | ALA3532523 | A | AUC (0 to infinity) in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 17. | ALA3532524 | A | Cmax in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 18. | ALA3532525 | A | Tmax in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 19. | ALA3532526 | A | Terminal elimination half life in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature | ||
| 20. | ALA3532527 | A | Apparent total clearance in monkey at 0.986 mg/kg, po administered via gavage by LC-MS/MS analysis | Macaca mulatta | 1 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!